Literature DB >> 31173763

Skeletal muscle differentiation drives a dramatic downregulation of RNA polymerase III activity and differential expression of Polr3g isoforms.

Caitlin McQueen1, Gideon L Hughes1, Mary E Pownall2.   

Abstract

Gene regulatory networks underpinning skeletal muscle determination and differentiation have been extensively investigated, providing molecular insights into how cell lineages are established during development. These studies have exclusively focused on the transcriptome downstream of RNA polymerase II (Pol II). RNA polymerase III (Pol III) drives the production of tRNAs and other small RNAs essential for the flow of genetic information from gene to protein and we have found that a specific isoform of a subunit unique to Pol III is expressed early in the myogenic lineage. This points to the possibility that additional regulatory networks exist to control the production of Pol III transcripts during skeletal muscle differentiation. We describe the differential expression of Polr3g and its alternate isoform Polr3gL during embryonic development and using a custom tRNA microarray, we demonstrate their distinct activity on the synthesis of tRNA isoacceptors. We show that Pol III dependent transcripts are dramatically down-regulated during the differentiation of skeletal muscle, as are mRNAs coding for Pol III associated proteins Brf1 and Brf2, while Polr3gL is up-regulated alongside contractile protein genes. Forcing Polr3g expression in this context results in a partial reversal of myogenic differentiation.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31173763     DOI: 10.1016/j.ydbio.2019.06.001

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  4 in total

1.  MAF1, a repressor of RNA polymerase III-dependent transcription, regulates bone mass.

Authors:  Ellen Phillips; Naseer Ahmad; Li Sun; James Iben; Christopher J Walkey; Aleksandra Rusin; Tony Yuen; Clifford J Rosen; Ian M Willis; Mone Zaidi; Deborah L Johnson
Journal:  Elife       Date:  2022-05-25       Impact factor: 8.713

Review 2.  RNA Polymerases I and III in development and disease.

Authors:  Kristin En Watt; Julia Macintosh; Geneviève Bernard; Paul A Trainor
Journal:  Semin Cell Dev Biol       Date:  2022-04-11       Impact factor: 7.499

3.  Silencing of BRF2 inhibits the growth and metastasis of lung cancer cells.

Authors:  Yuan Bian; Qiu Li; Qiaolian Li; Ruigen Pan
Journal:  Mol Med Rep       Date:  2020-06-26       Impact factor: 2.952

4.  The hRPC62 subunit of human RNA polymerase III displays helicase activity.

Authors:  Leyla El Ayoubi; Hélène Dumay-Odelot; Aleksandar Chernev; Fanny Boissier; Lionel Minvielle-Sébastia; Henning Urlaub; Sébastien Fribourg; Martin Teichmann
Journal:  Nucleic Acids Res       Date:  2019-11-04       Impact factor: 16.971

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.